Eating Disorders Trial, Recruiting (NCT07212075)

Eating Disorders Trial, Recruiting NCT07212075 Sponsor: Forschungsinstitut der Diabetes Akademie Mergentheim Condition: Eating Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07212075 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eating Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 80 years old
You have been diagnosed with type 1 diabetes, type 2 diabetes, or another specific form of diabetes
You have had diabetes for at least 1 year
You have a good enough understanding of German to participate
You are willing and able to give your consent to take part in the study

Who may not be able to join:

You are not able to give your own consent to participate
You have a significant memory or thinking condition, such as dementia
You have a serious illness or condition that could affect your ability to take part or might affect the study results — for example, certain cancer treatments, advanced heart disease, or a condition such as schizophrenia or a psychotic disorder (confirm with trial site)
You have a terminal illness (a condition that is not expected to be cured)
You are unable to get out of bed and move around

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07212075

Sponsor: Forschungsinstitut der Diabetes Akademie Mergentheim

Phase: Not Applicable

Status: Recruiting

Condition: Eating Disorders

More information: https://clinicaltrials.gov/study/NCT07212075

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 80 years old
You have been diagnosed with type 1 diabetes, type 2 diabetes, or another specific form of diabetes
You have had diabetes for at least 1 year
You have a good enough understanding of German to participate
You are willing and able to give your consent to take part in the study

Who may not be able to join:

You are not able to give your own consent to participate
You have a significant memory or thinking condition, such as dementia
You have a serious illness or condition that could affect your ability to take part or might affect the study results — for example, certain cancer treatments, advanced heart disease, or a condition such as schizophrenia or a psychotic disorder (confirm with trial site)
You have a terminal illness (a condition that is not expected to be cured)
You are unable to get out of bed and move around

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Forschungsinstitut der Diabetes Akademie Mergentheim

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

31 August 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Incidence of affective disorders from baseline to follow-up (per structured diagnostic interview); Incidence of anxiety disorders from baseline to follow-up (per structured diagnostic interview); Incidence of eating disorders at from baseline to follow-up (per structured diagnostic interview); Depressive symptoms: Incidence at 2-year Follow-up; Depressive symptoms: Remission at 2-year Follow-up; Anxiety symptoms: Incidence at 2-year Follow-up; Anxiety symptoms: Remission at 2-year Follow-up; Disordered eating behaviour: Incidence at 2-year Follow-up; Disordered eating behaviour: Remission at 2...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov